TABLE 2.
Variable | AD (n = 60) | VD (n = 60) | Control (n = 50) | p Value |
---|---|---|---|---|
GSDMD (pg/ml) | 3.19 ± 0.55 | 1.35 ± 0.34 | 0.37 ± 0.08 | <.001 |
T‐Tau (pg/ml) | 554.87 ± 65.76 | 300.40 ± 43.76 | 216.24 ± 35.65 | <.001 |
Tau181p (pg/ml) | 81.37 ± 22.43 | 42.27 ± 18.65 | 30.78 ± 11.43 | <.001 |
Aβ1−42 (pg/ml) | 512.13 ± 43.54 | 805.77 ± 33.84 | 912.23 ± 54.87 | <.001 |
IL‐1β (pg/ml) | 10.25 ± 2.16 | 1.95 ± 0.55 | 0.46 ± 0.11 | <.001 |
IL‐6 (pg/ml) | 14.17 ± 3.11 | 5.43 ± 1.55 | 2.26 ± 0.88 | <.001 |
GSDMD/T‐Tau (x10−3) | 5.7 ± 0.08 | 4.2 ± 0.03 | 1.7 ± 0.03 | <.001 |
GSDMD/Tau181p (x10−3) | 4.5 ± 0.03 | 3.1 ± 0.02 | 1.2 ± 0.02 | <.001 |
GSDMD/Aβ1−42 (x10−3) | 6.2 ± 0.04 | 1.6 ± 0.02 | 0.4 ± 0.01 | <.001 |